Development of a radioimmunoassay for the measurement of prostacyclin metabolites in unextracted plasma
- 1 January 1985
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 37 (1) , 177-183
- https://doi.org/10.1016/0049-3848(85)90044-1
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Plasma levels of 6-keto-prostaglandin F1α in normotensive subjects and patients with essential hypertensionProstaglandins, Leukotrienes and Medicine, 1983
- EPOPROSTENOL (PROSTACYCLIN) AND SEVERE ARTERIAL DISEASEThe Lancet, 1983
- Levels of plasma 6-keto-PGF1α in normotensive and essential hypertensive males with and without a family history of hypertensionProstaglandins, Leukotrienes and Medicine, 1983
- Plasma 6-keto-prostaglandin F1α in disorders involving hypokalemiaProstaglandins, Leukotrienes and Medicine, 1982
- Different results of plasma 6-keto-prostaglandin F1α measurements utilizing two antisera with apparently similar specificityProstaglandins, Leukotrienes and Medicine, 1982
- Plasma 6-keto-prostaglandin F1α: Fact or fictionThrombosis Research, 1982
- PROSTACYCLIN AND PRE-ECLAMPSIAThe Lancet, 1981
- The Clinical Significance of Platelet‐Associated IgG: a Study on 298 Patients with Various DisordersBritish Journal of Haematology, 1980
- VASCULAR PROSTACYCLIN MAY BE REDUCED IN DIABETES IN MANThe Lancet, 1979
- Use of a radioimmunoassay to study thrombin-induced release of PGI2 from cultured endotheliumThrombosis Research, 1979